We further uncovered a previously unappreciated integral anti-inflammatory and anti-metabolic effect of ROCK2 inhibition in human monocytes and Kupffer cells, two types of innate immune cells that actively contribute to liver disease progression. The gene discussed is ROCK2; the disease is liver disorder.